Tuesday 18 May 2021
Home      All news      Contact us      RSS      India
newindianexpress.com - 27 days ago

Bharat Biotech ramps up Covaxin production capacity to 700 million doses per annum

The company mentioned that inactivated vaccines, while highly safe, are extremely complex and expensive to manufacture, resulting in lower yields when compared to live virus vaccines.


Latest News
Hashtags:   

Bharat

 | 

Biotech

 | 

ramps

 | 

Covaxin

 | 

production

 | 

capacity

 | 

million

 | 

doses

 | 

annum

 | 

Sources